Virus Capture Kits
Get more from your samples. Knowing a virus is present in a sample and not being able to detect it is frustrating. Use the Nanotrap® Virus Capture Kit to concentrate viruses from complex biological matrices in order to have high quality input material for your downstream analytical methods.
PRODUCT DESCRIPTION
-
Nanotrap Virus Capture Kit improves the performance of your downstream analytical methods (e.g., PCR, Western blot, NGS, protein assays, infectivity assays) by capturing and concentrating whole virus from complex biological samples.
-
Compatible with multiple nucleic acid extraction kits.
-
Reduce your false negatives by increasing your starting sample volume by more than 10-fold.
-
Increase your assay sensitivity by capturing and concentrating low abundance viruses.
-
Nanotrap particles utilize affinity capture and enrichment to attract and bind low abundance viruses. Nanotrap particles do not utilize antibodies or other biomolecules as affinity molecules.
-
Nanotrap particles triple the nucleic acid yield as compared to QIAGEN column only.
-
Incorporating Nanotrap technology into your workflow is simple. No more than 4 steps added to your current workflow or just 7 steps total if you perform the capture, concentration, and extraction with the Ceres Nanosciences platform - compared to an average of 12-plus with the competition.
Nanotrap® particle technology can enhance other sample preparation products to improve downstream analytical performance. The following data highlight the improvement in viral RNA isolation for flu A detection via RT-PCR using the Nanotrap Virus Capture Kit.
Reaching the lower limit of detection for an assay can be challenging within a large dynamic range. This kit provides a reproducible method for improving assay sensitivity you need for your assay. In 2 mL spiked transport media samples, the Nanotrap technology significantly improved the nucleic acid yield of a commercially available extraction kit (Figure 5), taking the detectable amount of Influenza A down to less than 1 copy/µL.
Let the Nanotrap technology concentrate virus from larger volumes without disrupting your assay’s sample input volume requirement. An array of sample input volumes for influenza A concentrations across four sample volumes processed using the Nanotrap Virus Capture Kit are shown in comparison with the 150 µL QIAGEN column input volume.
